Contact US

You have any questions or need to contact us about something? Reach out, we’d be happy to hear from you!

ask.pathinvestments@gmail.com

  • twitter
  • facebook
  • linkedin

All the Latest

Welcome to Path Investments

Please reload

Archive

Please reload

Tags

Our Recent Posts

Please reload

March 30, 2017

Voclosporin has shown success in its Phase II AURA-LV clinical trials. Phase II results indicated very strong complete remission rates at 24-weeks, surpassing its primary endpoints and a follow-up Phase IIb study demonstrated stronger remission rates at 48-weeks. If AURORA Phase III trials demonstrate as much success as the Phase II trial, Aurinia...

March 3, 2017

Considering AMD’s substantial growth in 2016, investors have become wary if AMD could continue it’s growth in 2017. AMD Ryzen chips have shown to be more than capable against Intel’s Kaby Lake processors, and AMD’s VEGA GPU looks ready to compete against NVIDIA’s GTX 1080i. I believe in 2017, AMD will regain market share in both the CPU and GPU chi...

Please reload

 
 
 

©2017 by Path Investments.

  • twitter
  • facebook
  • linkedin